1 August 2023 false Taxfiler 2024.6 15043094business:PrivateLimitedCompanyLtd2023-08-012024-08-31 150430942023-07-31 150430942023-08-012024-08-31 15043094business:AuditExemptWithAccountantsReport2023-08-012024-08-31 15043094business:FilletedAccounts2023-08-012024-08-31 150430942024-08-31 15043094business:Director12023-08-012024-08-31 15043094business:Director22023-08-012024-08-31 15043094business:RegisteredOffice2023-08-012024-08-31 15043094core:WithinOneYear2024-08-31 15043094core:ShareCapitalcore:PreviouslyStatedAmount2024-08-31 15043094core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-08-31 15043094core:PreviouslyStatedAmount2024-08-31 15043094business:SmallEntities2023-08-012024-08-31 15043094countries:EnglandWales2023-08-012024-08-31 15043094core:PlantMachinery2023-08-012024-08-31 15043094core:ComputerEquipment2023-08-012024-08-31 15043094core:IntangibleAssetsOtherThanGoodwill2023-07-31 15043094core:IntangibleAssetsOtherThanGoodwill2023-08-012024-08-31 15043094core:IntangibleAssetsOtherThanGoodwill2024-08-31 15043094core:PlantMachinery2023-07-31 15043094core:PlantMachinery2024-08-31 iso4217:GBP xbrli:pure
Company Registration No. 15043094 (England and Wales)
GENETIX RESEARCH LTD Unaudited accounts for the period from 1 August 2023 to 31 August 2024
GENETIX RESEARCH LTD Unaudited accounts Contents
Page
- 2 -
GENETIX RESEARCH LTD Company Information for the period from 1 August 2023 to 31 August 2024
Directors
Arun Jaitly Karen Yarely Castro
Company Number
15043094 (England and Wales)
Registered Office
30 CHURCHILL PLACE LONDON E14 5RE ENGLAND
Accountants
NRV Tax Ltd Suites 12 & 13 Chantal House 13-17 High Beech Road Loughton IG10 4BN
- 3 -
GENETIX RESEARCH LTD Statement of financial position as at 31 August 2024
2024 
Notes
£ 
Fixed assets
Intangible assets
105,935 
Tangible assets
798,531 
904,466 
Current assets
Debtors
768,350 
Cash at bank and in hand
119,560 
887,910 
Creditors: amounts falling due within one year
(936,932)
Net current liabilities
(49,022)
Net assets
855,444 
Capital and reserves
Called up share capital
10,000 
Profit and loss account
845,444 
Shareholders' funds
855,444 
For the period ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 November 2024 and were signed on its behalf by
Arun Jaitly Director Company Registration No. 15043094
- 4 -
GENETIX RESEARCH LTD Notes to the Accounts for the period from 1 August 2023 to 31 August 2024
1
Statutory information
GENETIX RESEARCH LTD is a private company, limited by shares, registered in England and Wales, registration number 15043094. The registered office is 30 CHURCHILL PLACE, LONDON, E14 5RE, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% Straight-Line Depreciation
Computer equipment
20% Straight-Line Depreciation
Intangible fixed assets
Amortization has not been provided on intellectual property since its not a substantial amount.
Other operating income
Other operating income is the grant income received from Queen Mary University of London of £1,436,647
- 5 -
GENETIX RESEARCH LTD Notes to the Accounts for the period from 1 August 2023 to 31 August 2024
4
Intangible fixed assets
Other 
£ 
Cost
At 1 August 2023
- 
Additions
131,935 
At 31 August 2024
131,935 
Amortisation
At 1 August 2023
- 
Charge for the period
26,000 
At 31 August 2024
26,000 
Net book value
At 31 August 2024
105,935 
Breakdown of intangible assets: 5 year's lease of £130,000 (Amortized over 5 years) Intellectual property £1,935
5
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 August 2023
- 
Additions
998,164 
At 31 August 2024
998,164 
Depreciation
Charge for the period
199,633 
At 31 August 2024
199,633 
Net book value
At 31 August 2024
798,531 
6
Debtors
2024 
£ 
Amounts falling due within one year
VAT
298,105 
Accrued income and prepayments
470,245 
768,350 
- 6 -
GENETIX RESEARCH LTD Notes to the Accounts for the period from 1 August 2023 to 31 August 2024
7
Creditors: amounts falling due within one year
2024 
£ 
Trade creditors
37,675 
Taxes and social security
48,184 
Other creditors
13,831 
Loans from directors
836,817 
Accruals
425 
936,932 
8
Average number of employees
During the period the average number of employees was 10.
- 7 -